ORGS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (10 May 2024 @ 10:37):

Stats
Today's Volume	21 326.00
Average Volume	237 125
Market Cap	18.76M
EPS	$0 ( 2024-05-09 )
Next earnings date	( $0 ) 2024-08-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.290
ATR14	$0.0110 (2.01%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Miller Victor	Sell	25 000	Stock Option (Right to Buy)
2024-04-01	Miller Victor	Buy	25 000	Common Stock
2024-02-01	Safier Jacob	Buy	10 100	Common Stock (par value $0.01)
2024-01-31	Safier Jacob	Buy	5 000	Common Stock (par value $0.01)
2024-01-30	Safier Jacob	Buy	25 000	Common Stock (par value $0.01)

INSIDER POWER
93.64
Last 93 transactions
Buy: 2 511 105 \| Sell: 463 608

Volume Correlation

Long: 0.27 (neutral)

Short: -0.63 (weak negative)

Signal:(48.907) Neutral

Orgenesis Inc Correlation

10 Most Positive Correlations
VTYX	0.863
QRTEA	0.85
SOUN	0.849
IPWR	0.848
RGTI	0.847
ARQQ	0.846
LFVN	0.842
RCM	0.832
FEMY	0.831
ICLR	0.825

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Orgenesis Inc Correlation - Currency/Commodity

-0.40
( neutral )

-0.43
( neutral )

0.00
( neutral )

0.21
( neutral )

Orgenesis Inc Financials

Annual	2023
Revenue:	$530 000
Gross Profit:	$-5.73M (-1 080.19 %)
EPS:	$-1.910

FY	2023
Revenue:	$530 000
Gross Profit:	$-5.73M (-1 080.19 %)
EPS:	$-1.910

FY	2022
Revenue:	$36.03M
Gross Profit:	$15.59M (43.26 %)
EPS:	$-0.480

FY	2021
Revenue:	$35.50M
Gross Profit:	$-1.14M (-3.22 %)
EPS:	$0.744

Financial Reports:

No articles found.

Orgenesis Inc

Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.